Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters











Publication year range
1.
Oral Dis ; 2023 Sep 20.
Article in English | MEDLINE | ID: mdl-37731277

ABSTRACT

OBJECTIVES: To investigate the effects of dietary folate and sex on histopathology of oral squamous cell carcinoma in mice. MATERIALS AND METHODS: Mice (C57Bl/6, 30/sex) were fed either a deficient folate or sufficient folate diet. Vehicle or 4-nitroquinoline1-oxide (50 µg/mL) in vehicle were administered in drinking water for 20 weeks, followed by 6 weeks of regular drinking water. Oral lesions were observed weekly. Tongues were studied for histopathologic changes. Immunohistochemical techniques were used to measure cell proliferation (Ki67+), and to quantify expression of folate receptor, reduced folate carrier, and proton-coupled folate transporter. T cells, macrophages, and neutrophils were counted and normalized to area. RESULTS: All 4NQO-treated mice developed oral tumors. Dietary folate level did not affect tumor burden. More tumors were observed on the ventral aspect of the tongue than in other locations within the oral cavity. 4-nitroquinoline-1-oxide-treated mice displayed 27%-46% significantly lower expression of all three folate transport proteins; diet and sex had no effect on folate transporter expression. T-cell and neutrophil infiltration in tongues were 9.1-fold and 18.1-fold increased in the 4-nitroquinoline-1-oxide-treated mouse tongues than in controls. CONCLUSION: Treatment with 4NQO was the primary factor in determining cancer development, decreased folate transport expression, and lymphoid cell infiltration.

2.
PLoS One ; 17(5): e0268891, 2022.
Article in English | MEDLINE | ID: mdl-35639668

ABSTRACT

Risk factors for liver cancer include tobacco use, alcohol consumption, obesity, and male sex. Administration of 4-nitroquinonline-1-oxide (4NQO) in drinking water mimics the effects of tobacco and leads to oral carcinoma in mice. This study compared the effects of diets high and low in saturated fat (HF and LF, respectively), and sex, on liver histopathology in 4NQO-treated mice and controls. We hypothesized that 4NQO would cause histopathological changes in liver, and that a HF diet would increase hepatic pathology when compared to the LF diet. Mice (C57Bl/6, 36/sex), were divided into a low fat (10 kcal% fat; LF) or high fat (60 kcal% fat, HF) diet. Mice were further subdivided into one of 3 water treatment groups for 17 weeks: water (control), vehicle (1.25% propylene glycol in water [PG]), or 4NQO in (50 µg/ml; 4NQO). All mice were subsequently given water alone for 6 more weeks. Upon euthanasia, livers were harvested, fixed, sectioned, and stained with hematoxylin and eosin (H&E). H&E slides were graded for histopathology; frozen liver samples were analyzed for triglyceride content. Trichrome stained sections were graded for fibrosis. CD3+ T cells, CD68+ macrophages, and Ly6+ neutrophils were detected by immunohistochemistry. Compared to water controls, 4NQO-treatment caused mouse liver histopathological changes such as fibrosis, and increases in hepatic neutrophils, T cells, and macrophages. HF diet exacerbated pathological changes compared to LF diet. Male controls, but not females, demonstrated severe steatosis and increased triglyceride content. 4NQO treatment decreased hepatic fat accumulation, even in animals on a HF diet. In conclusion, this murine model of oral cancer may serve as a model to study the effects of tobacco and diet on liver.


Subject(s)
4-Nitroquinoline-1-oxide , Dietary Fats , 4-Nitroquinoline-1-oxide/toxicity , Animals , Fibrosis , Liver , Male , Mice , Mice, Inbred C57BL , Triglycerides
3.
Nutr Neurosci ; 25(10): 2057-2065, 2022 Oct.
Article in English | MEDLINE | ID: mdl-34042561

ABSTRACT

OBJECTIVE: One-carbon (1C) metabolism is a metabolic network that integrates nutritional signals with biosynthesis, redox homeostasis, and epigenetics. There are sex differences in hepatic 1C metabolism, however, it is unclear whether sex differences in 1C impact the brain. The aim of this study was to investigate if sex modulates the effects of dietary folic acid deficiency, the main component of 1C, in brain tissue using a mouse model. METHODS: Male and female C57Bl/6J mice were placed on a folic acid deficient (FD) or control diet (CD) at six weeks until six months of aged. After which brain tissue and serum were collected for analysis. In brain tissue, hippocampal volume, morphology, and apoptosis as well as cortical acetylcholine metabolism were measured. RESULTS: Male and female FD mice had reduced serum levels of folate. Both males and females maintained on a FD showed a decrease in the thickness of the hippocampal CA1-CA3 region. Interestingly, there was a sex difference in the levels of active caspase-3 within the CA3 region of the hippocampus. In cortical tissue, there were increased levels of neuronal ChAT and reduced levels of AChE in FD females and male mice. CONCLUSIONS: The results indicated that FD impacts hippocampal morphology and cortical neuronal acetylcholine metabolism. The data from our study indicate that there was only one sex difference and that was in hippocampal apoptosis. Our study provides little evidence that sex modulates the effects of dietary folate deficiency on hippocampal morphology and cortical neuronal acetylcholine metabolism.


Subject(s)
Folic Acid Deficiency , Acetylcholine/metabolism , Carbon , Caspase 3/metabolism , Diet , Female , Folic Acid , Hippocampus/metabolism , Humans , Male
4.
Cells ; 10(2)2021 02 17.
Article in English | MEDLINE | ID: mdl-33671410

ABSTRACT

Schwann cells plastically change in response to nerve injury to become a newly reconfigured repair phenotype. This cell is equipped to sense and interact with the evolving and unusual physical conditions characterizing the injured nerve environment and activate intracellular adaptive reprogramming as a consequence of external stimuli. Summarizing the literature contributions on this matter, this review is aimed at highlighting the importance of the environmental cues of the regenerating nerve as key factors to induce morphological and functional changes in the Schwann cell population. We identified four different microenvironments characterized by physical cues the Schwann cells sense via interposition of the extracellular matrix. We discussed how the physical cues of the microenvironment initiate changes in Schwann cell behavior, from wrapping the axon to becoming a multifunctional denervated repair cell and back to reestablishing contact with regenerated axons.


Subject(s)
Cues , Nerve Regeneration/physiology , Peripheral Nerve Injuries/metabolism , Schwann Cells/cytology , Humans , Myelin Sheath/metabolism , Phenotype
5.
Oral Dis ; 27(2): 215-225, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32640482

ABSTRACT

OBJECTIVE: To compare the effects of dietary fat and sex on murine oral squamous cell carcinoma pathology. MATERIALS AND METHODS: Male and female C57Bl/6 mice (36/sex) received a low-fat (10 kcal%) or high-fat (60 kcal%) diet. Water (control), vehicle, or 4-nitroquinoline-1-oxide in vehicle (50 µg/ml) was provided for 17 weeks followed by six additional weeks of water. Oral lesion development was recorded weekly. Histopathologic changes in tongues were examined, and T cells (CD3+), macrophages (CD68+), and neutrophils (Ly6+) were quantified. RESULTS: All 4-nitroquinoline-1-oxide-treated mice developed oral tumors. High-fat diet exacerbated pathology, demonstrated by an increased final tumor burden (10.9 ± 4.5 vs. 7.9 ± 2.5, mm/mouse, p < .05; high-fat diet vs. low-fat diet, respectively), and a greater histopathology score. When dietary groups were combined, 4-nitroquinoline-1-oxide-treated males displayed higher histopathology scores than females (4.2 ± 0.3 vs. 3.6 ± 0.2, respectively, p < .05). Lymphoid cell infiltration was greater in the 4-nitroquinoline-1-oxide mouse tongues than controls: T cells (14.0 vs. 0.96 cells/mm2 ), macrophages (3.6 vs. 1.8 cells/mm2 ), and neutrophils (12.0 vs. 0.38 cells/mm2 ). CONCLUSION: High-fat diet and male sex increased the pathology of 4-nitroquinoline-1-oxide-induced oral cancer. Elevated lymphoid cell infiltration contributed to disease pathology.


Subject(s)
Carcinoma, Squamous Cell , Mouth Neoplasms , Tongue Neoplasms , 4-Nitroquinoline-1-oxide/toxicity , Animals , Dietary Fats/adverse effects , Female , Male , Mice , Mouth Neoplasms/chemically induced
6.
Article in English | MEDLINE | ID: mdl-30853412

ABSTRACT

OBJECTIVES: The purpose of this study was to assess the expression of the 3 major folate transporters-folate receptors (FRs), reduced folate carrier (RFC), and proton-coupled folate transporter (PCFT)-in oral squamous cell carcinoma (OSCC). We hypothesized that patterns of expression of folate transporters would be different in OSCC compared with normal oral epithelium. STUDY DESIGN: We used immunohistochemistry to examine the expression of FR, RFC, and PCFT in 15 primary specimens collected from patients with OSCC, 2 human cadaveric samples of OSCC, and 12 normal human cadaveric oral tissues from a medical gross anatomy laboratory. Possible correlations between the expression of each folate transporter and patients' clinical data were determined. RESULTS: All 3 folate transporters were highly expressed in normal oral epithelium. In contrast, OSCC samples generally demonstrated low expression of FR, RFC, and PCFT, with wide distribution in the invading cancer cells. There were no differences in folate transporter expression between OSCC samples collected from patients and from human cadavers. The lowest expression of FR and PCFT characterized less-differentiated tumors, and the lowest expression of RFC correlated with higher lymph node involvement. CONCLUSIONS: Human oral cancer samples expressed decreased amounts of all 3 major folate transport proteins compared with controls from normal cadaveric oral tissues.


Subject(s)
Carcinoma, Squamous Cell , Mouth Neoplasms , Folic Acid , Folic Acid Antagonists , Folic Acid Transporters , Humans , Reduced Folate Carrier Protein
7.
J Cardiothorac Vasc Anesth ; 32(1): 178-186, 2018 02.
Article in English | MEDLINE | ID: mdl-29107589

ABSTRACT

OBJECTIVE: The purpose of the study was to evaluate the impact of intravenous metamizole on platelet inhibition by aspirin in patients with coronary artery disease early after on-pump coronary artery bypass grafting (CABG). DESIGN: Prospective, single-blind, randomized trial. SETTING: Tertiary referal hospital. PARTICIPANTS: The study comprised 43 patients with multivessel coronary artery disease undergoing CABG. INTERVENTIONS: Patients were randomized to postoperative intravenous metamizole ± opioids (study group; n = 23) or opioids alone (control group; n = 20). Aspirin was withheld at least 7 days before the surgery and reinitiated (300 mg) immediately after the procedure prior to metamizole use, and continued daily thereafter (150 mg). Platelet function was evaluated using multielectrode impedance aggregometry (acid-induced platelet activation [ASPI] and collagen-induced platelet activation [COL] test), P-selectin expression and urinary 11-dehydro-thromboxane B2 (11-DTXB2) level at baseline, postoperative day (POD) 0, POD 1, POD 2, and POD 6. Residual platelet reactivity (RPR) was defined as ASPI test >400 AU*min. MEASUREMENTS AND MAIN RESULTS: In all study participants, postoperative ASPI test value moderately decreased (1058.2 v 966.6 AU*min, p = 0.047), urinary 11-DTXB2 level increased (923.4 v 4367.3 pg/mg, p < 0.001), and P-selectin expression and COL test value remained stable postprocedure. The decreases of ASPI (p = 0.146) and COL test (p = 0.642), and P-selectin expression (p = 0.318) did not differ between both groups. Patients in the control group had higher postoperative increase of urinary 11-DTXB2 level (p = 0.001). The prevalence of RPR was high and comparable between study and control groups (day 1, 95.6% v 100%, p = 0.535; day 6, 100% v 90%, p = 0.21). Multivariate analysis revealed that metamizole use did not predict the fluctuations of ASPI and COL test values and P-selectin expression, yet it independently predicted postoperative change of 11-DTXB2 level (b = -0.518, p = 0.001). CONCLUSIONS: Intravenous metamizole preceded by a loading dose of aspirin did not modify platelet response to aspirin in the postoperative period after CABG.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Aspirin/administration & dosage , Coronary Artery Bypass/methods , Coronary Artery Disease/therapy , Dipyrone/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Aged , Anti-Inflammatory Agents, Non-Steroidal/blood , Aspirin/blood , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/blood , Dipyrone/blood , Drug Interactions/physiology , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , Platelet Activation/drug effects , Platelet Activation/physiology , Platelet Aggregation Inhibitors/blood , Prospective Studies , Single-Blind Method
8.
Kardiol Pol ; 74(7): 634-43, 2016.
Article in English | MEDLINE | ID: mdl-26779855

ABSTRACT

BACKGROUND: Clinical studies have suggested increased risk of thrombotic events after planned cessation of clopidogrel therapy, due to increased platelet reactivity (platelet rebound); however, in many studies platelet function was not assessed before introducing clopidogrel. Patients who are scheduled to stop clopidogrel therapy, do it abruptly, so a gradual drug cessation might provide a beneficial treatment strategy. AIM: To determine whether a clopidogrel discontinuation results in platelet rebound hyperaggregability with increased activity compared to pre-treatment values and to assess whether abrupt or tapering clopidogrel cessation may affect platelet reactivity. METHODS: Patients with stable coronary artery disease (n = 49), on chronic acetylsalicylic acid treatment, who underwent coronary angiography, and were scheduled for elective percutaneous coronary intervention with stent implantation were en-rolled. Patients were randomised to either a tapering clopidogrel discontinuation during a two-week period (tapering group, n = 25) or abrupt drug cessation (abrupt group, n = 24). After 12 months of dual antiplatelet therapy with clopidogrel and acetylsalicylic acid, we performed three follow-up visits with blood sampling. Platelet aggregation was assessed using a mul-tiple electrode aggregometer at inclusion, at cessation day, and seven and 14 days after complete clopidogrel discontinuation. The primary endpoint was the level of adenosine-diphosphate (ADP)-induced platelet aggregation. We also analysed platelet function in the ASPI test and platelet count as secondary endpoints. RESULTS: In 36 patients included in the main analysis, we found significant differences between the two study groups in the levels of ADP-induced platelet aggregation at days seven and 14 after cessation of clopidogrel (p = 0.004 and p = 0.04, respectively). In the abrupt group, platelet aggregation returned to the values similar to baseline at day seven. There were no significant differences between baseline, seven, and 14 days after drug cessation (p = 0.92 and p = 0.37, respectively). However, in the tapering group, ADP values at seven and 14 days after drug cessation were significantly decreased, comparing to baseline (p < 0.0001 and p = 0.009, respectively). For the ASPI test and platelet count we did not find significant differ-ences between the groups. All values returned to levels similar to the baseline. During the follow-up there were no serious cardiovascular events or bleedings. CONCLUSIONS: Tapering vs. abrupt discontinuation of clopidogrel treatment results in significantly lower platelet aggregation values after 14 days from complete drug cessation. We found no evidence of a platelet rebound effect.


Subject(s)
Coronary Artery Disease/drug therapy , Percutaneous Coronary Intervention , Platelet Aggregation Inhibitors/administration & dosage , Ticlopidine/analogs & derivatives , Withholding Treatment , Aged , Aspirin/therapeutic use , Clopidogrel , Coronary Artery Disease/surgery , Female , Humans , Male , Middle Aged , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation Inhibitors/therapeutic use , Platelet Function Tests , Random Allocation , Ticlopidine/administration & dosage , Ticlopidine/pharmacology , Ticlopidine/therapeutic use
9.
Endokrynol Pol ; 62(6): 499-505, 2011.
Article in English | MEDLINE | ID: mdl-22144215

ABSTRACT

BACKGROUND: Obesity has been associated with low-grade systemic inflammation, potentially leading to insulin resistance, type 2 diabetes, dyslipidemia, and cardiovascular diseases. Even moderate weight loss through dietary changes and physical exercise is effective in preventing and managing obesity-associated disorders. The aim of this study was to determine the effect of weight loss in response to a lifestyle modification on the serum levels of inflammatory markers in obese children and adolescents. MATERIAL AND METHODS: Fifty obese subjects completed a six-month programme consisting of combined hypocaloric diet and moderate physical activity. High-sensitive C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen (FB), white blood count (WBC), glucose, insulin, insulin resistance index (HOMA IR), glycosylated haemoglobin (HbA(1c)), lipids as well as systolic (SBP) and diastolic blood pressure (DBP) were measured before and after intervention. RESULTS: Patients had a 5.3 ± 3.4 kg average weight loss, with significant decreases of SDS-BMI, percentage of body fat, SDS-waist, SBP and DBP, HOMA-IR, HbA(1c) and reductions in serum IL-6, CRP, WBC, FB. In the multivariable linear models, changes in percentage of body fat and HOMA-IR were positively associated with favourable changes in inflammatory parameters. CONCLUSION: This study demonstrates that weight reduction after successful lifestyle intervention results in improvements of blood inflammatory markers in obese children and adolescents.


Subject(s)
Blood Glucose/metabolism , Diet, Reducing , Insulin Resistance/physiology , Life Style , Obesity/blood , Weight Loss/physiology , Adolescent , Biomarkers/metabolism , Body Mass Index , Cardiovascular Diseases/etiology , Cardiovascular Diseases/prevention & control , Child , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/prevention & control , Energy Intake , Female , Humans , Linear Models , Male , Obesity/complications , Obesity/therapy , Patient Education as Topic , Risk Factors
10.
Endokrynol Pol ; 62(6): 506-11, 2011.
Article in English | MEDLINE | ID: mdl-22144216

ABSTRACT

BACKGROUND: There is increasing evidence that vitamin D deficiency is common and has been associated with several non-bone related outcomes, including insulin resistance, type 2 diabetes and cardiovascular disease. The influences of gender, puberty, and adiposity on serum hydroxyvitamin D (25-OH-D) levels and the relationship between 25-OH-D and insulin resistance in obese children were studied. MATERIAL AND METHODS: Age, gender, pubertal stage, weight status (standard deviation score of body mass index: BMI-SDS, percentage body fat, waist circumference), 25-OH-D levels, and insulin resistance index calculated by homeostasis model assessment (HOMA-IR) were evaluated in 64 obese adolescents. Multivariable linear regression was used to determine factors associated with decreased serum 25-OH-D levels and to study the relationship between 25-OH-D and HOMA-IR. RESULTS: Median serum 25-OH-D level was 10.1 ng/mL (25.2 nmol/L). 14% of patients were vitamin D-sufficient (25-OH-D ≥ 20 ng/mL), 36% had intermediate values (11-19 ng/mL), and 50% were deficient (25-OH-D ≤ 10 ng/mL). In the multivariable model, older age, puberty, higher value of percentage of body fat, and the presence of acanthosis nigricans (AN) were all negatively associated with 25-OH-D. Lower 25-OH-D levels were also associated with higher blood glucose, insulin and HOMA-IR after adjustment for puberty and SDS-BMI. Summer positively correlated with 25-OH-D level. CONCLUSION: Our study confirms that obesity is a risk factor for vitamin D deficiency. Hypovitaminosis D, common in obese adolescents at risk for type 2 diabetes (older age, puberty, acanthosis nigricans) is associated with worse insulin resistance.


Subject(s)
Insulin Resistance/physiology , Obesity/blood , Vitamin D Deficiency/blood , Vitamin D/analogs & derivatives , Adolescent , Age Factors , Body Mass Index , Child , Female , Humans , Linear Models , Male , Sex Factors , Vitamin D/blood
12.
Alcohol ; 42(4): 237-47, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18411007

ABSTRACT

Extensive evidence indicates that ethanol (alcohol) has immunomodulatory properties. Many of its effects on innate immune response are dose dependent, with acute or moderate use associated with attenuated inflammatory responses, and heavy ethanol consumption linked with augmentation of inflammation. Ethanol may modify innate immunity via functional alterations of the cells of the innate immune system. Mounting evidence indicates that ethanol can diversely affect antigen recognition and intracellular signaling events, which include activation of mitogen activated protein kinases, and NFkappaB, mediated by Toll-like receptors, leading to altered inflammatory responses. The mechanism(s) underlying these changes may involve dose-dependent effects of ethanol on the fluidity of cell membrane, resulting in interference with the timely assembly or disassembly of lipid rafts. Ethanol could also modify cell activation by specific interactions with cell membrane molecules.


Subject(s)
Alcohol Drinking/immunology , Ethanol/adverse effects , Immunity, Innate/drug effects , Immunologic Factors/adverse effects , Signal Transduction/drug effects , Animals , Dose-Response Relationship, Drug , Humans , Inflammation/chemically induced , Inflammation/immunology , Inflammation Mediators/metabolism , Membrane Fluidity/drug effects , Membrane Fluidity/immunology , Membrane Microdomains/drug effects , Membrane Microdomains/immunology , Phagocytes/drug effects , Phagocytes/immunology , Phagocytosis/drug effects , Signal Transduction/immunology , Toll-Like Receptors/metabolism
13.
Ann Acad Med Stetin ; 54(2): 14-21, 2008.
Article in Polish | MEDLINE | ID: mdl-19374226

ABSTRACT

INTRODUCTION: Tumor necrosis factor alpha (TNF-alpha) is suspected to play a role in obesity and concomitant metabolic disturbances. The aim of the study was to determine fasting serum concentrations of TNF-alpha in overweight and obese children and to analyse the relationships between TNF-alpha and insulin resistance and lipid disturbances. The additional aim was to assess correlations between TNF-alpha and total fat mass, body mass index (BMI), WHR, leptin and plasminogen activator inhibitor type 1 (PAI-1), as the factor of increased risk of atheromatosis. MATERIAL AND METHODS: The study was performed in a group of 160 children aged 6-18.5 years: 127 overweight or obese and 33 healthy lean children (control group). The anthropometric measurements, BMI, WHR, fat-free mass, Tanner pubertal stage and blood pressure were determined. The fasting serum concentrations of TNF-alpha, glucose, insulin, lipids and fibrinogen were analysed in studied children. In overweight and obese subjects oral glucose tolerance test (OGTT) was done, serum leptin and plasma PAI-1 concentrations were determined. Atherogenic and insulin resistance indexes were counted. Statistic analysis was done. RESULTS AND CONCLUSIONS: The serum TNF-alpha concentration in overweight and obese children and lean controls were comparable. This fact doesn't deny the role of TNF-alpha in pathogenesis of obesity. TNF-alpha concentration grows in serum of girls according to degree of abdominal obesity, determined with increase of WHR. Fat-free mass and BMI don't influence TNF-alpha level. Carbohydrate disturbances in obese children may not depend only on TNF-alpha. There are relationships between TNF-alpha and decreased HDL cholesterol and increased triglycerides (TG) levels in serum of overweight and obese children, mainly in II-III pubertal stage. Special care should be provided for children with excessive body weight at the beginning of puberty because of increased intensity of metabolic syndrome in this period and greater risk of early atheromatosis. Special care should be also provided for boys with increased TG serum levels, because of growing atherogenesis risk, determined with higher plasma concentration of PAI-1 in them and positive correlation between TNF-alpha and PAI-1. Regulation ofleptin production and secretion may also be under the control of other factors than TNF-alpha.


Subject(s)
Lipid Metabolism , Obesity/metabolism , Tumor Necrosis Factor-alpha/blood , Adolescent , Anthropometry , Body Mass Index , Child , Cholesterol, HDL/blood , Female , Humans , Insulin Resistance , Leptin/metabolism , Male , Plasminogen Activator Inhibitor 1/metabolism , Puberty/physiology , Triglycerides/blood
14.
Shock ; 25(6): 581-5, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16721265

ABSTRACT

This study was designed to determine whether the acute-phase response in aged mice is altered by interleukin (IL) 6 deficiency. Young and aged wild-type (WT) and IL-6 knockout (KO) BALB/C female mice were injected with lipopolysaccharide (LPS; 1.5 microg/g body weight). After 24 h, aged IL-6 KO mice had an improved survival when compared with aged WT mice. Serum levels of IL-6 in aged WT animals given LPS were determined and, as expected, were significantly higher when compared with young LPS-treated WT animals (P<0.05). Serum levels of the acute-phase protein, serum amyloid A, were 50% lower in aged LPS-treated IL-6 KO mice relative to aged WT mice given LPS (P<0.001). In contrast, the induction of LPS-binding protein was not affected by age or IL-6 deficiency in LPS-treated animals. Circulating levels of corticosterone were markedly reduced in aged LPS-treated IL-6 KO mice relative to aged WT mice given LPS. These data indicate that IL-6 is an important contributor to the outcome of the acute-phase response of aged individuals challenged with endotoxin. We conclude that the absence of IL-6, a cytokine that contributes to the elevated basal proinflammatory state observed in aging, can improve the ability of aged mice to withstand an otherwise lethal challenge of bacterial endotoxin.


Subject(s)
Acute-Phase Reaction/blood , Aging/blood , Carrier Proteins/blood , Interleukin-6/deficiency , Lipopolysaccharides/toxicity , Membrane Glycoproteins/blood , Serum Amyloid A Protein/analysis , Acute-Phase Proteins , Acute-Phase Reaction/chemically induced , Animals , Female , Lipopolysaccharides/administration & dosage , Mice , Mice, Inbred BALB C , Mice, Knockout
15.
Przegl Lek ; 63(8): 645-9, 2006.
Article in Polish | MEDLINE | ID: mdl-17441375

ABSTRACT

Homocysteine is known as an independent risk factor of atherosclerosis. The aim of this study was assessment of serum homocysteine concentrations in obese children and evaluation of possible relationship between homocysteine and risk factors of atherosclerosis. 498 children with simple obesity were included into our study. There was a significant correlation between serum homocysteine levels and both traditional and new risk factors of atherosclerosis. The issues confirm a necessity of evaluation serum homocysteine levels of obese children in estimation of cardiovascular disease risk.


Subject(s)
Atherosclerosis/blood , Atherosclerosis/epidemiology , Homocysteine/blood , Hypertension/epidemiology , Obesity/blood , Obesity/epidemiology , Adolescent , Atherosclerosis/genetics , Biomarkers/metabolism , Body Mass Index , Child , Comorbidity , Female , Folic Acid/blood , Genetic Predisposition to Disease/epidemiology , Humans , Male , Obesity/genetics , Obesity, Morbid/blood , Obesity, Morbid/embryology , Obesity, Morbid/epidemiology , Obesity, Morbid/genetics , Poland/epidemiology , Risk Factors , Statistics, Nonparametric , Vitamin B 12/blood
16.
J Immunol ; 174(1): 456-63, 2005 Jan 01.
Article in English | MEDLINE | ID: mdl-15611271

ABSTRACT

Ethanol is known to increase susceptibility to infections, in part, by suppressing macrophage function. Through TLRs, macrophages recognize pathogens and initiate inflammatory responses. In this study, we investigated the effect of acute ethanol exposure on murine macrophage activation mediated via TLR2, TLR4, and TLR9. Specifically, the study focused on the proinflammatory cytokines IL-6 and TNF-alpha and activation of p38 and ERK1/2 MAPKs after a single in vivo exposure to physiologically relevant level of ethanol followed by ex vivo stimulation with specific TLR ligands. Acute ethanol treatment inhibited IL-6 and TNF-alpha synthesis and impaired p38 and ERK1/2 activation induced by TLR2, TLR4, and TLR9 ligands. We also addressed the question of whether ethanol treatment modified activities of serine/threonine-specific, tyrosine-specific phosphatases, and MAPK phosphatase type 1. Inhibitors of three families of protein phosphatases did not restore ethanol-impaired proinflammatory cytokine production nor p38 and ERK1/2 activation. However, inhibitors of serine/threonine protein phosphatase type 1 and type 2A significantly increased IL-6 and TNF-alpha levels, and prolonged activation of p38 and ERK1/2 when triggered by TLR4 and TLR9 ligands. In contrast, with TLR2 ligand stimulation, TNF-alpha production was reduced, whereas IL-6 levels, and p38 and ERK1/2 activation were not affected. In conclusion, acute ethanol exposure impaired macrophage responsiveness to multiple TLR agonists by inhibiting IL-6 and TNF-alpha production. Mechanism responsible for ethanol-induced suppression involved inhibition of p38 and ERK1/2 activation. Furthermore, different TLR ligands stimulated IL-6 and TNF-alpha production via signaling pathways, which showed unique characteristics.


Subject(s)
Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Inflammation/immunology , Macrophages/drug effects , Membrane Glycoproteins/drug effects , Receptors, Cell Surface/drug effects , Animals , Blotting, Western , Cytokines/biosynthesis , Cytokines/drug effects , Down-Regulation , Enzyme Activation/drug effects , Extracellular Signal-Regulated MAP Kinases/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , Inflammation/metabolism , Macrophages/immunology , Macrophages/metabolism , Male , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Mice , Receptors, Cell Surface/immunology , Receptors, Cell Surface/metabolism , Toll-Like Receptor 2 , Toll-Like Receptor 4 , Toll-Like Receptors , p38 Mitogen-Activated Protein Kinases/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
17.
J Leukoc Biol ; 75(2): 342-9, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14634059

ABSTRACT

Age-related changes in immunity render elderly individuals more susceptible to infections than the young. Previous work by our laboratory and others showed that macrophages from aged mice are functionally impaired. Macrophages produce proinflammatory cytokines, tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-6, when stimulated with lipopolysaccharide (LPS), which signals through Toll-like receptor-4 (TLR4) and requires activation of mitogen-activated protein kinases (MAPKs). We investigated whether aging is associated with alterations in TNF-alpha and IL-6 production and MAPK expression and activation in thioglycollate-elicited peritoneal macrophages from mice. Kinetics and LPS dose-responsiveness of macrophage TNF-alpha production did not differ by age. Unstimulated macrophages did not differ by age in their cytokine production. However, LPS-stimulated (100 ng/mL) cultures from aged mice produced 100 +/- 30 pg/mL TNF-alpha and 6000 +/- 2000 pg/mL IL-6, and those from young mice produced 280 +/- 50 pg/mL and 10,650 +/- 10 pg/mL, respectively (P<0.05). Likewise, levels of activated MAPKs did not differ by age in unstimulated macrophages, and LPS-stimulated macrophages from aged mice had <70% activated p38 and c-jun NH(2)-terminal kinase (JNK) than those of young controls. Of particular interest, we observed >25% reduction of total p38 and JNK in macrophages from aged mice relative to young. In addition, surface TLR4 levels did not vary with age. We conclude that macrophages from aged mice exhibited suppressed proinflammatory cytokine production, which correlated with diminished total levels and LPS-stimulated activation of p38 and JNK. These observations suggest that decreased MAPK expression could be a mechanism responsible for age-related deterioration of the immune system.


Subject(s)
Aging/immunology , Cytokines/biosynthesis , Membrane Glycoproteins/physiology , Mitogen-Activated Protein Kinases/biosynthesis , Receptors, Cell Surface/physiology , Age Factors , Animals , Female , Inflammation/immunology , Interleukin-6/biosynthesis , JNK Mitogen-Activated Protein Kinases , Kinetics , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinases/analysis , Toll-Like Receptor 4 , Toll-Like Receptors , Tumor Necrosis Factor-alpha/biosynthesis , p38 Mitogen-Activated Protein Kinases
18.
J Leukoc Biol ; 75(3): 553-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14634061

ABSTRACT

Acute ethanol consumption has been linked to an increase in infectious complications in trauma and burn patients. Ethanol modifies production of a variety of macrophage-derived immunoregulatory mediators. Lipopolysaccharide (LPS), a potent stimulator of inflammatory responses in macrophages, activates several intracellular signaling pathways, including mitogen-activated protein kinases (MAPK). In the current study, we investigated the effect of acute ethanol exposure on in vivo activation of p38 and extracellularly regulated kinases 1 and 2 (ERK1/2) MAPK in murine macrophages and the corresponding, LPS-stimulated interleukin (IL)-6 production. We demonstrated that a single dose of ethanol transiently down-regulated p38 and ERK1/2 activation levels (3-24 h after treatment) and impaired IL-6 synthesis. Ethanol-related reduction in IL-6 production was not further affected by the presence of inhibitors of p38 and ERK1/2 (SB 202190 and PD 98059, respectively). These results demonstrate that acute ethanol exposure can impair macrophage IL-6 production and indicate that this effect may result from ethanol-induced alterations in intracellular signaling through p38 and ERK1/2.


Subject(s)
Ethanol/pharmacology , Interleukin-6/biosynthesis , Macrophages/drug effects , Mitogen-Activated Protein Kinases/metabolism , Adjuvants, Immunologic/pharmacology , Animals , Down-Regulation/drug effects , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/drug effects , Signal Transduction/drug effects , p38 Mitogen-Activated Protein Kinases
SELECTION OF CITATIONS
SEARCH DETAIL